Won-Tae Cha
Fortuna: 18 M $ al 31/08/2026
Fortuna: 18 M $ al 31/08/2026
Won-Tae Cha currently works at Cha Biotech Co., Ltd., as Chief Executive Officer from 2026, Cha Medical & Bio Group, as Vice Chairman, and Stem Cell & Regenerative Medicine International, Inc., as Director.
Mr. Cha received his undergraduate degree from Duke University, Masters Business Admin degree from Massachusetts Institute of Technology, graduate degree from Yale University, and doctorate degree from Yonsei University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CHA BIOTECH CO., LTD. 3,34 % | 09/09/2026 | 3.110.518 ( 3,34 % ) | 18 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CHABIOTECH CO.,LTD. | Director Ejecutivo | 04/03/2026 |
Stem Cell & Regenerative Medicine International, Inc.
Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cha Biotech Co., Ltd.
Cha Biotech Co., Ltd. Electronic ComponentsElectronic Technology Manufactures and designs optical, digital, and medical products and related cell therapy and biological products | Electronic Technology |
Stem Cell & Regenerative Medicine International, Inc.
Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.